Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer

<div>The association between serum miR-629 level and therapeutic responses as well as survival in NSCLC. (a) Serum miR-629 level was significantly increased following surgical treatment. (b, c) The patients in the high serum miR-629 group had worse overall survival and disease-free survival than those in the low serum miR-629 group.</div>

Disease Markers

fig4

Figure 4

Figure 4: Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer 